Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sally Moore

Showing results (31-40 of 69) with videos related to

Pageof 7
Sort By:
British Journal of Haematology|August 1, 2014
The bone marrow stromal compartment in multiple myeloma patients retains capability for osteogenic differentiation in vitro: defining the stromal defect in myelomaDeepika Kassen, Sally Moore, Laura Percy, et al.
Lung Cancer (Amsterdam, Netherlands)|December 13, 2006
Recurrent responses to non-small cell lung cancer brain metastases with erlotinibSanjay Popat, Sarah Hughes, Panos Papadopoulos, et al.
BMJ (Clinical Research Ed.)|November 16, 2002
Nurse led follow up and conventional medical follow up in management of patients with lung cancer: randomised trialSally Moore, Jessica Corner, Jo Haviland, et al.
Ejhaem|January 27, 2025
Real-world characteristics and outcomes of patients with multiple myeloma receiving second-line treatment in EnglandSally Moore, Laura Cornic, Christina-Jane Crossman-Barnes, et al.
European Journal of Haematology|June 28, 2020
Myeloma care adaptations in the UK during SARS-CoV-2 pandemic: Challenges and measurable outcomesFaouzi Djebbari, Fotios Panitsas, Faye A Sharpley, et al.
Plos One|February 22, 2020
Treatment-free interval as an additional measure of efficacy in a large UK dataset of transplant ineligible myeloma patientsFaouzi Djebbari, Faye A Sharpley, Susan McLain-Smith, et al.
BMJ Quality & Safety|March 17, 2018
What can patients tell us about the quality and safety of hospital care? Findings from a UK multicentre survey studyJane K O'Hara, Caroline Reynolds, Sally Moore, et al.
British Journal of Haematology|August 19, 2011
Autologous stem cell transplantation remains beneficial for patients relapsing after R-CHOP chemotherapy and who respond to salvage chemotherapySally Moore, Karl Peggs, Kirsty Thomson, et al.
Health Expectations : an International Journal of Public Participation in Health Care and Health Policy|May 15, 2023
Unpacking the Cinderella black box of complex intervention development through the Partners at Care Transitions (PACT) programme of researchJenni Murray, Ruth Baxter, Rebecca Lawton, et al.
Maternal & Child Nutrition|July 15, 2025
A Cross-Sectional Association Between Serum Aflatoxin and Micronutrient Status Among Children Aged 6-24 Months in Rural TanzaniaNaelijwa Mshanga, Neema Kassim, Suchaya Sonto, et al.
Pageof 7

Showing results (31-40 of 69) with videos related to

Sort By:
Pageof 7
British Journal of Haematology|August 1, 2014
The bone marrow stromal compartment in multiple myeloma patients retains capability for osteogenic differentiation in vitro: defining the stromal defect in myelomaDeepika Kassen, Sally Moore, Laura Percy, et al.
Lung Cancer (Amsterdam, Netherlands)|December 13, 2006
Recurrent responses to non-small cell lung cancer brain metastases with erlotinibSanjay Popat, Sarah Hughes, Panos Papadopoulos, et al.
BMJ (Clinical Research Ed.)|November 16, 2002
Nurse led follow up and conventional medical follow up in management of patients with lung cancer: randomised trialSally Moore, Jessica Corner, Jo Haviland, et al.
Ejhaem|January 27, 2025
Real-world characteristics and outcomes of patients with multiple myeloma receiving second-line treatment in EnglandSally Moore, Laura Cornic, Christina-Jane Crossman-Barnes, et al.
European Journal of Haematology|June 28, 2020
Myeloma care adaptations in the UK during SARS-CoV-2 pandemic: Challenges and measurable outcomesFaouzi Djebbari, Fotios Panitsas, Faye A Sharpley, et al.
Plos One|February 22, 2020
Treatment-free interval as an additional measure of efficacy in a large UK dataset of transplant ineligible myeloma patientsFaouzi Djebbari, Faye A Sharpley, Susan McLain-Smith, et al.
BMJ Quality & Safety|March 17, 2018
What can patients tell us about the quality and safety of hospital care? Findings from a UK multicentre survey studyJane K O'Hara, Caroline Reynolds, Sally Moore, et al.
British Journal of Haematology|August 19, 2011
Autologous stem cell transplantation remains beneficial for patients relapsing after R-CHOP chemotherapy and who respond to salvage chemotherapySally Moore, Karl Peggs, Kirsty Thomson, et al.
Health Expectations : an International Journal of Public Participation in Health Care and Health Policy|May 15, 2023
Unpacking the Cinderella black box of complex intervention development through the Partners at Care Transitions (PACT) programme of researchJenni Murray, Ruth Baxter, Rebecca Lawton, et al.
Maternal & Child Nutrition|July 15, 2025
A Cross-Sectional Association Between Serum Aflatoxin and Micronutrient Status Among Children Aged 6-24 Months in Rural TanzaniaNaelijwa Mshanga, Neema Kassim, Suchaya Sonto, et al.
Pageof 7